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ABSTRACT
Objective: Angiogenesis plays an important role in embryonic development and various physiological processes. However, excessive angiogenesis is 
associated with several pathological conditions including cancer. Clematis is a genus of about 300 species within the buttercup family Ranunculaceae. 
It is native to the India, where has been used as folk medicine for the treatment of various ailments. This work is aimed to evaluate the antiangiogenesis 
activity in the crude methanolic extract of Clematis buchaniana plant.
Methods: The entire aerial parts of C. buchaniana were extracted by soxhelation in methanol. Then, the solvent was evaporated to dryness to yield 
the dried crude extract of C. buchaniana. Then, the extract was subjected to preliminary phytochemical screening to determine the active constituents 
for effective pharmacological activity. The in-vitro antiangiogenesis effects were later evaluated using chorioallantoic membrane model carried out by 
incubation in fresh chicken’s eggs.
Results: The crude methanolic extract of C. buchaniana was found to have slight ability to inhibit angiogenesis that was evaluated by visualization.
Conclusion: C. buchaniana plant extract inhibits angiogenesis by blocking normal vascularization in chick embryo. The ability of inhibiting angiogenic 
process in eggs by this extract can provide us an herbal anticancer agent in future for further scrutiny.
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INTRODUCTION
Angiogenesis, the formation of new blood vessels is a biological process 
that plays a fundamental role in embryonic development [1]. It plays 
a key role in a various physiological and pathological process such as 
embryonic development, wound healing, chronic inflammation, tumor 
growth, and metastasis [2,3]. Angiogenesis blockade has been shown to 
be an effective strategy in inhibiting tumor growth and metastasis [4]. 
Endothelial cells in tumor bed tend to be more susceptible to cytotoxic 
agents due to their high proliferation rate. In addition, endothelial cells, 
on the contrary to cancerous cells, are genetically stable as they do not 
undergo mutations, and hence more sensitive to apoptotic effects of the 
cytotoxic agents. Thus, these features of endothelial cells make them 
a compelling target for antiangiogenesis treatment [5]. Consequently, 
cytotoxic agents pose as candidates as antiangiogenic agents on top of 
their potent activity in causing the death of cancerous cells. Extensive 
studies have been conducted to assess the role of oxidative stress, and 
hence the use of antioxidants in the prevention of many diseases such 
as cancer, inflammation, and atherosclerosis [6]. The use of traditional 
herbs for medicine has been a common practice from stone age. From 
years ago man has always scrutinized his biotic world for medicines 
which mainly contains plants as the most precious store for medicines. 
Keeping it in view familiarity increased with the various species of 
Clematis (Ranunculaceae) which made it an essential garden plant 
in today’s period. Clematis is a genus of about 300 species within the 
buttercup family Ranunculaceae. Their garden hybrids have always 
been popular among gardeners, beginning with Clematis jackmanii, a 
garden since 1862; more hybrid cultivars are being produced constantly. 
They are mainly obtained from Chinese and Japanese origin. Some 
other species of Clematis has been evaluated for its anti-inflammatory, 
cytotoxic, and antimicrobial effects but Clematis buchaniana has not 
been studied much. The whole plant of C. buchaniana was traditionally 
used in Nepalese medicinal plants for stronger immunity, cooling 
effect, and asthma [7]. Due to its traditional uses and other established 
pharmacological activities on the different species of Clematis and 
minimal pharmacological data on C. buchaniana made it an intense 
area for studying antiangiogenic activity. The main purpose of this 
antiangiogenic activity on C. buchaniana was actually to determine 
the ability in the extract to inhibit angiogenesis in a growing and well 
incubated fresh chicken’s egg at 37°C [8].
METHODS
Collection and authentication of plant material
The entire plant of C. buchaniana was collected from the village of 
Kotma Kalimath (Kedarnath region) hilly areas of Garhwal and then 
further identified and authenticated by the Botanical Survey of India, 
Dehradun. The voucher specimen no. 115904 was deposited in 
herbarium. Further, the identified plant was washed to remove any 
dust and other earthy matter, further was shade, dried, and powdered 
with laboratory mill. The crushed plant was subjected for extraction.
Chemicals used
Various chemicals used in this activity are crude dried extract, ethanol 
(for sterilization), water for injection as the solvent used in dosing of 
eggs, β1,4-galactan sulfate (standard) pellets.
Instruments used
The various instruments used in performing this activity are given in 
Table 1.
Preparation of crude plant extract
About 200 g of the dried plant was kept in the Soxhlet apparatus 
(Borosil), and then, it was subjected to Soxhlation using methanol as 
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the menstruum to obtain methanolic extract of the entire crude plant 
C. buchaniana. The obtained methanolic extract was filtered, and the 
excessive solvent was evaporated using vaccum rotator evaporator 
under reduced pressure. After evaporation of the solvent, the crude 
extract was placed in the desiccator for removal of remaining moisture 
from the extract to dry it completely. Then, the percentage yield of the 
dried crude extract was evaluated using the given formula that yielded 
to about 52 g of crude dry extract.
% Yield = Weight of extract (g)*100/Weight of dry powder (g)
Antiangiogenesis activity
The antiangiogenic activity was performed as follows using 
chorioallantoic membrane (CAM) assay method:
CAM assay
Fresh fertile eggs were bought from the local poultry farm of Lalpur and 
were kept for incubation at 37.5°C in humidified incubator (humidity 
55-60%). Ethanol (70%) was used for sterilizing the surface of eggs. 
After 3 days of incubation with the help of sterile syringe, 5-8 ml of 
albumin was sucked and removed from each egg by making a window 
of 1 cm in diameter at the blunt end of the eggs or by directly pricking 
the needle through egg shell (this is done to get better quantification of 
CAM vasculature).The egg was sealed up with the help of sterile plastic 
film tape and again incubated for 24 hrs.
Procedure of preparation and administration of sample solutions
Sterile water for injection was used as vehicle in the preparation 
of sample solutions. Sample solution of varying concentrations 
was prepared after calculating effective dose 50% from lethal dose 
50% that were found to be 200 and 2000 mg/kg. Then, the eggs 
were weighed individually, and average weight was calculated 
accordingly the dose of the sample was found as 10 mg/kg for which 
a concentration of 20 mg/ml was prepared. The pH of the solution 
was maintained between 6.5 and 7.5 by the addition of diluted HCl 
and NaOH solutions. 0.5 ml of above concentration of sample solution 
was applied with the help of syringe from the window in all groups 
of growing embryos on the 5th day of their incubation. Again kept for 
incubation for next 24 hrs. The pictures were clicked at every stage 
after incubation of all three groups (control, test, and standard). 
The β1, 4-galactan sulfate was taken as standard, and similar 
concentration was prepared as that of the sample solution. The 
extent of degeneration of CAM vasculature was noted on the 7th day 
of incubation in all three groups [9-15].
RESULTS AND DISUSSION
Antiangiogenic activity
Angiogenesis, tightly modulated through a balance of positive and 
negative regulatory factors, is to operate by proangiogenic growth 
factors such as vascular endothelial growth factor, which in turn induce 
activation of their respective receptors on the surface of endothelial 
cells, resulting in angiogenesis, therefore, identification of new agents 
that inhibit the growth in endothelial cell could have potential to 
inhibit tumor angiogenesis and subsequently repress tumor growth. 
After 3-5 days of treatment, untreated control eggs gave branching 
pattern of tube-like capillaries. In contrast, capillary tube formation 
was slightly suppressed in eggs, which was treated with C. buchaniana 
(10 µg/0.5 ml) [16].
Fig 1 shows the effect of Clematis buchaniana methanolic extract on 
angiogenesis inhibition of blood vessels in control and test group.
The result of antiangiogenic activity is shown in Table 2.
CONCLUSION
This study has been subjected to following aspects of an important 
herbal medicinal plant C. buchaniana (family Ranunculaceae), the study 
included antiangiogenic activity via CAM assay method. Angiogenesis is 
an important initiative process in case of many diseases such as tumor, 
cataract, and psoriasis. The methanolic extract of C. buchaniana shows 
slight inhibitory activity against this process. These herbs may have 
promising antitumor activity if given as an adjuvant in chemotherapy 
or in targeting other angiogenesis-related diseases.
The anti-inflammatory and antiangiogenic activity of C. buchaniana need 
further more detailed study in the path of isolation and authentication 
of screened phytochemicals responsible for above activities of this 
medicinal drug [17-21].
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